In this informative video, Tawnya Meier, Associate Medical Director–Safety at NAMSA, explains when a Data Safety Monitoring Board (DSMB) is necessary in clinical research—and why it plays a critical role in protecting patient safety and ensuring study integrity.
What You’ll Learn:
- DSMB Basics: What a DSMB is and the role it plays in clinical trials
- When It’s Required: Key criteria that trigger the need for a DSMB, including study risk level, complexity, and regulatory expectations
- Regulatory Perspective: How FDA guidance influences DSMB requirements and what sponsors should consider during study planning
Whether you’re designing a high-risk study or navigating regulatory expectations, this video offers clear, expert-driven guidance to help you determine when a DSMB is essential.